Contact your GP or diabetes specialist nurse within 2448 hours if: The injection site reaction persists beyond one week or worsens progressively You develop signs of infection at the injection site (increasing pain, warmth, pus, or red streaking) The rash spreads beyond the injection site but without severe symptoms You experience recurrent reactions with each injection The reaction significantly impacts your quality of life or ability to continue treatment If you cannot reach your GP and need urgent advice, contact NHS 111

Ulwazi@Wits University #pharmacology #pharmacy #patientcentredcare #semaglutide To view or add a comment, sign in More Relevant Posts - , , - Eli Lilly and Company announced positive topline results from the ATTAIN-MAINTAIN Phase 3 trial, where orforglipron, a once-daily #oral #GLP-1 receptor agonist, helped participants maintain #weightloss over 52 weeks after switching from injectable incretin therapies like Wegovy(semaglutide) injection 2.4 mg HCP or Zepbound (tirzepatide) HCP
Patients with a history of depression may be at increased risk of recurrent depression or other mood disorders while taking QSYMIA [see Adverse Reactions (6.1)]
These programs are most valuable for patients managing complex metabolic conditions who benefit from close, coordinated monitoring over an extended period
Retatrutide: Not approved
The GLP-1 receptor is a G protein-coupled receptor that sits on the surface of cells throughout your body